163 related articles for article (PubMed ID: 35793574)
41. Detection of
Bai H; Xia J; Zhao X; Gong Z; Zhang D; Xiong L
J Clin Pathol; 2019 May; 72(5):379-385. PubMed ID: 30787028
[TBL] [Abstract][Full Text] [Related]
42. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis.
Chen D; Guo J; Huang H; Tian L; Xie Y; Wu Q
BMC Med; 2023 Nov; 21(1):467. PubMed ID: 38012727
[TBL] [Abstract][Full Text] [Related]
44. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
45. Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood.
Wang BH; Li YY; Han JZ; Zhou LY; Lv YQ; Zhang HL; Zhao L
Oncotarget; 2017 May; 8(19):31692-31704. PubMed ID: 28404957
[TBL] [Abstract][Full Text] [Related]
46. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
[TBL] [Abstract][Full Text] [Related]
47. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
48. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
Zeng S; Lin C; Huang Y
Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
[TBL] [Abstract][Full Text] [Related]
49. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C
Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250
[TBL] [Abstract][Full Text] [Related]
50. Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.
Benesova L; Ptackova R; Halkova T; Semyakina A; Svaton M; Fiala O; Pesek M; Minarik M
Pathol Oncol Res; 2022; 28():1610308. PubMed ID: 35837614
[No Abstract] [Full Text] [Related]
51. Utility of urinary circulating tumor DNA for EGFR mutation detection in different stages of non-small cell lung cancer patients.
Li F; Huang J; Ji D; Meng Q; Wang C; Chen S; Wang X; Zhu Z; Jiang C; Shi Y; Liu S; Li C
Clin Transl Oncol; 2017 Oct; 19(10):1283-1291. PubMed ID: 28497422
[TBL] [Abstract][Full Text] [Related]
52. Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer.
Yin W; Wang X; Li Y; Wang B; Song M; Hulbert A; Chen C; Yu F
Oncol Lett; 2020 Jul; 20(1):967-973. PubMed ID: 32566027
[TBL] [Abstract][Full Text] [Related]
53. [Application Value of ctDNA-based MRD Dedection
in Early Stage Non-small Cell Lung Cancer after Radical Surgery].
Dou S; Xie H; Yang L
Zhongguo Fei Ai Za Zhi; 2021 Dec; 24(12):862-866. PubMed ID: 34743498
[TBL] [Abstract][Full Text] [Related]
54. Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data.
Chen H; Wang A; Wang J; He Z; Mao Y; Liu L
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1867-1876. PubMed ID: 32221744
[TBL] [Abstract][Full Text] [Related]
55. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.
Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q
J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
[TBL] [Abstract][Full Text] [Related]
57. Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.
Passiglia F; Rizzo S; Rolfo C; Galvano A; Bronte E; Incorvaia L; Listi A; Barraco N; Castiglia M; Calo V; Bazan V; Russo A
Curr Cancer Drug Targets; 2018; 18(7):697-705. PubMed ID: 29521235
[TBL] [Abstract][Full Text] [Related]
58. HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer.
Abou-Zeid A; Hashad D; Baess A; Mosaad M; Tayae E
BMC Cancer; 2023 Apr; 23(1):329. PubMed ID: 37038139
[TBL] [Abstract][Full Text] [Related]
59. Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non-small cell lung cancer patients.
Li H; Ma ZL; Li B; Pan YJ; Xiang JQ; Zhang YW; Sun YH; Hou T; Lizaso A; Chen Y; Li X; Hu H
Cancer Med; 2021 Dec; 10(23):8377-8386. PubMed ID: 34664796
[TBL] [Abstract][Full Text] [Related]
60. Multiplex Digital Methylation-Specific PCR for Noninvasive Screening of Lung Cancer.
Zhao Y; O'Keefe CM; Hsieh K; Cope L; Joyce SC; Pisanic TR; Herman JG; Wang TH
Adv Sci (Weinh); 2023 Jun; 10(16):e2206518. PubMed ID: 37039321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]